{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:38:33Z","timestamp":1792751913839,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.104057","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:20:23Z","timestamp":1791933623000},"page":"104057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["VKORC1L1 contributes to glioblastoma progression and temozolomide resistance by sustaining vitamin K reduction and limiting ferroptosis-associated lipid peroxidation"],"prefix":"10.1016","volume":"104","author":[{"given":"Yao-Wen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Long","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jian","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.104057_bib1","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.18632\/oncotarget.26765","article-title":"Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells","volume":"10","author":"Beaudin","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2026.104057_bib2","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","article-title":"iPLA2\u03b2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2026.104057_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tice.2026.104057_bib4","article-title":"Ferroptosis: the dawn of reversing drug resistance in digestive cancers","volume":"13","author":"Chen","year":"2026","journal-title":"Genes Dis."},{"key":"10.1016\/j.tice.2026.104057_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41419-022-05044-9","article-title":"High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1\/MRP1 upregulation","volume":"13","author":"de Souza","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tice.2026.104057_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tice.2026.104057_bib7","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1039\/D4TB00353E","article-title":"Detecting labile heme and ferroptosis through 'turn-on' fluorescence and lipid droplet localization post Fe(2+) sensing","volume":"12","author":"Dubey","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.tice.2026.104057_bib8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fimmu.2017.01521","article-title":"Requirement of gamma-carboxyglutamic acid modification and phosphatidylserine binding for the activation of Tyro3, Axl, and Mertk receptors by growth arrest-specific 6","volume":"8","author":"Geng","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.104057_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11060-013-1268-2","article-title":"Combination of anti-VEGF therapy and temozolomide in two experimental human glioma models","volume":"116","author":"Grossman","year":"2014","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.tice.2026.104057_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-07-0862","article-title":"Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme","volume":"14","author":"Hutterer","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2026.104057_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2025.124757","article-title":"Analytical insights into the epidemiology of glioma and treatment modalities","volume":"206","author":"Ji","year":"2026","journal-title":"World Neurosurg."},{"key":"10.1016\/j.tice.2026.104057_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96501","article-title":"VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo","volume":"3","author":"Lacombe","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tice.2026.104057_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-025-02046-4","article-title":"Overcoming temozolomide resistance in glioma: recent advances and mechanistic insights","volume":"13","author":"Li","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tice.2026.104057_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41419-025-07969-3","article-title":"USP7 promotes temozolomide resistance by stabilizing MGMT in glioblastoma","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tice.2026.104057_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-026-00973-4","article-title":"Comprehensive transcriptomics and proteome analysis to identify prognostic risk factors for MYCN non-amplified high-risk neuroblastoma","volume":"20","author":"Liu","year":"2026","journal-title":"Hum. Genom."},{"key":"10.1016\/j.tice.2026.104057_bib16","first-page":"50","article-title":"Glioblastoma: epidemiology and imaging-based review","volume":"108","author":"Madour","year":"2025","journal-title":"R. I. Med. J. (2013)"},{"key":"10.1016\/j.tice.2026.104057_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12040856","article-title":"The 4-hydroxynonenal-protein adducts and their biological relevance: are some proteins preferred targets?","volume":"12","author":"Milkovic","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.tice.2026.104057_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tice.2026.104057_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s42255-023-00821-y","article-title":"Diverse biological functions of vitamin K: from coagulation to ferroptosis","volume":"5","author":"Mishima","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tice.2026.104057_bib20","doi-asserted-by":"crossref","first-page":"9876","DOI":"10.18632\/oncotarget.7130","article-title":"Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo","volume":"7","author":"Onken","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2026.104057_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-54463-7","article-title":"VKORC1L1-mediated vitamin K recycling counters ferroptosis to promote endothelial repair","volume":"16","author":"Repges","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.104057_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1358\/mf.1999.21.6.541918","article-title":"In vivo establishment of T98G human glioblastoma","volume":"21","author":"Rubenstein","year":"1999","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.tice.2026.104057_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115694","article-title":"Advances in anti-cancer drug development: metformin as anti-angiogenic supplemental treatment for glioblastoma","volume":"25","author":"Shah","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.104057_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tice.2026.104057_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133116","article-title":"Theranostic potential of adaptive cold atmospheric plasma with temozolomide to checkmate glioblastoma: an in vitro study","volume":"14","author":"Soni","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2026.104057_bib26","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1538-7836.2005.01419.x","article-title":"The vitamin K cycle","volume":"3","author":"Stafford","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.tice.2026.104057_bib27","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 classification of central nervous system tumours: a practical update on what neurosurgeons need to know-a minireview","volume":"164","author":"Torp","year":"2022","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.tice.2026.104057_bib28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","article-title":"Prospects for ferroptosis therapies in cancer","volume":"6","author":"Ubellacker","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.tice.2026.104057_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-026-00416-5","article-title":"Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches","volume":"7","author":"Wang","year":"2026","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.tice.2026.104057_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tice.2026.104057_bib31","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1093\/neuonc\/noaf177","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"27","author":"Wen","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.tice.2026.104057_bib32","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1074\/jbc.M110.210971","article-title":"Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1) mediates vitamin K-dependent intracellular antioxidant function","volume":"286","author":"Westhofen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tice.2026.104057_bib33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s10143-025-03647-2","article-title":"Socioeconomic status as a determinant of survival in glioblastoma: a systematic review and meta-analysis","volume":"48","author":"Wijaya","year":"2025","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.tice.2026.104057_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.113","article-title":"Molecular insights of Gas6\/TAM in cancer development and therapy","volume":"8","author":"Wu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tice.2026.104057_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tice.2026.104057_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103362","article-title":"LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis","volume":"77","author":"Xin","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.tice.2026.104057_bib37","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.cmet.2023.06.014","article-title":"Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.tice.2026.104057_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from chinese glioma patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626007536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626007536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:46:25Z","timestamp":1792748785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626007536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":38,"alternative-id":["S0040816626007536"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.104057","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VKORC1L1 contributes to glioblastoma progression and temozolomide resistance by sustaining vitamin K reduction and limiting ferroptosis-associated lipid peroxidation","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.104057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104057"}}